{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2007"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2038811"],"location":["Singapore","Hong Kong","Cyprus","Czechia","Thailand","Portugal","Russia","South Korea","Sweden","Austria","Ireland","Poland","Brazil","Slovakia","Serbia","Bulgaria","Chile","Bosnia and Herzegovina","Colombia","Argentina","Romania","Hungary","Ukraine","United Kingdom","India","Spain","Canada","Belgium","Norway","Taiwan","Mexico","South Africa","Australia","Germany"],"study_start_month":["6"],"keyword":["Irinotecan","Sunitinib","Levoleucovorin","Leucovorin","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer","description":"The purpose of the study is to evaluate the safety and efficacy of FOLFIRI (Irinotecan, Leucovorin and 5 Fluorouracil) chemotherapy when combined with sunitinib or FOLFIRI chemotherapy without adding sunitinib as the first line treatment of patients with metastatic colorectal cancer.","dates":{"creation":"2007-06-15"},"accession":"2038811","cross_references":{"ClinicalTrials___gov":["NCT00457691"],"Clinical Trials Registry - India":["CTRI-2011-091-000025"]}}